Viewing Study NCT05607992



Ignite Creation Date: 2024-05-06 @ 6:15 PM
Last Modification Date: 2024-10-26 @ 2:45 PM
Study NCT ID: NCT05607992
Status: COMPLETED
Last Update Posted: 2024-06-25
First Post: 2022-10-27

Brief Title: Brief Internet-delivered CBT After ACS
Sponsor: Karolinska Institutet
Organization: Karolinska Institutet

Study Overview

Official Title: Brief Internet-delivered Exposure-based Therapy to Reduce Post-traumatic Stress Symptoms and Cardiac Anxiety After Acute Coronary Syndrome a Pilot Randomized Clinical Trial
Status: COMPLETED
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the present pilot study is to evaluate the feasibility and potential efficacy of a brief internet-delivered CBT protocol provided early after acute coronary syndrome ACS
Detailed Description: Acute coronary syndrome ACS myocardial infarction MI or unstable angina UA is one of the leading causes of mortality and health loss globally ACS is a stressful and potentially life-threatening cardiovascular event and many patients develop symptoms of post-traumatic stress PTSS and cardiac anxiety post ACS which have been shown to negatively affect patients long-term cardiovascular prognosisThe aim of the proposed pilot study is to develop and evaluate a brief internet-delivered exposure-based CBT intervention provided early following ACS to reduce ACS-related PTSS cardiac anxiety and increase physical activity and quality of life Patients with recent ACS 4 weeks to 6 months and with elevated PTSS and anxiety will be eligible After informed consent patients will be randomized to internet-delivered CBT N15 or to a wait-list control group N15 The treatment is a 5 week therapist-guided internet-delivered intervention which includes imaginal exposure interoceptive exposure and exposure in-vivo Assessments will be conducted at baseline immediate post-treatment and 2- and 6- months after treatment The wait-list will be crossed over to CBT after completion of the 2 month follow-up

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None